HTG Molecular Diagnostics to Present at H.C. Wainwright’s 23rd Annual Global Investment Conference
Details for the presentation are below:
Management will also be available for 1x1 meetings. If you would like to request a meeting, please email firstname.lastname@example.org.
HTG is focused on NGS-based molecular profiling. The company’s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. Its mission is to empower precision medicine. To learn more, visit www.htgmolecular.com.
Phone: (617) 430-7577
Source: HTG Molecular Diagnostics, Inc.